1. Home
  2. CCEL vs RMCO Comparison

CCEL vs RMCO Comparison

Compare CCEL & RMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cryo-Cell International Inc.

CCEL

Cryo-Cell International Inc.

HOLD

Current Price

$3.63

Market Cap

29.6M

Sector

Health Care

ML Signal

HOLD

Logo Royalty Management Holding Corporation

RMCO

Royalty Management Holding Corporation

N/A

Current Price

$2.67

Market Cap

35.3M

Sector

Miscellaneous

ML Signal

N/A

Company Overview

Basic Information
Metric
CCEL
RMCO
Founded
1989
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Managed Health Care
Multi-Sector Companies
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
29.6M
35.3M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
CCEL
RMCO
Price
$3.63
$2.67
Analyst Decision
Hold
Buy
Analyst Count
1
1
Target Price
N/A
N/A
AVG Volume (30 Days)
6.4K
35.7K
Earning Date
04-14-2026
05-14-2026
Dividend Yield
4.26%
0.35%
EPS Growth
N/A
N/A
EPS
0.01
N/A
Revenue
$25,384,279.00
N/A
Revenue This Year
N/A
$209.10
Revenue Next Year
N/A
$133.33
P/E Ratio
$363.15
N/A
Revenue Growth
9.76
N/A
52 Week Low
$2.72
$1.12
52 Week High
$5.43
$5.00

Technical Indicators

Market Signals
Indicator
CCEL
RMCO
Relative Strength Index (RSI) 47.48 52.25
Support Level $3.14 $2.17
Resistance Level $3.64 $3.06
Average True Range (ATR) 0.19 0.26
MACD 0.01 0.04
Stochastic Oscillator 61.69 60.00

Price Performance

Historical Comparison
CCEL
RMCO

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

About RMCO Royalty Management Holding Corporation

Royalty Management Holding Corp is formed to invest or purchase assets that have near and medium-term income potential to provide RMC with accretive cash flow from which it can reinvest in new assets or expand cash flow from those existing assets. These assets typically are natural resources assets (including real estate and mining permits), patents, intellectual property, and emerging technologies.

Share on Social Networks: